Share Twitter LinkedIn Facebook Email John Fruehauf, MD of UC Irvine Health explains clinicians could change the way they manage their patients by lowering doses and possibly impacting treatment that way.
AACR IO 2025: Revolutionary Insights into Desmoplastic Melanoma Treatment – Kari L Kendra, MD, PHD AACR 5 Mins Read
What Are the Latest Melanoma Treatment Advances? [87 Slides] Justin Moyers, MD Melanoma and Skin 3 Mins Read